| Previous Close | 35.99 |
| Open | 36.06 |
| Bid | 35.85 x 1100 |
| Ask | 35.96 x 100 |
| Day's Range | 35.91 - 36.19 |
| 52 Week Range | 29.83 - 36.21 |
| Volume | 200 |
| Avg. Volume | 17,208,645 |
| Market Cap | 213.93B |
| Beta | 1.06 |
| PE Ratio (TTM) | 26.31 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 1.28 (3.61%) |
| Ex-Dividend Date | 2017-08-02 |
| 1y Target Est | N/A |
Markit•53 minutes agoSee what the IHS Markit Score report has to say about Pfizer Inc.
Pfizer Inc NYSE:PFE
- Market Realist•1 hour ago
These Pfizer’s Products Are Now Losing Market Share
Pfizer's (PFE) Essential Health segment reported a fall in overall revenues in 2Q17, driven by the loss of exclusivity of Celebrex and Zyvox.
- Reuters•15 hours ago
Versartis growth hormone drug fails key study, shares sink
Versartis Inc said its experimental drug for the treatment of growth hormone deficiency in children did not meet the main goal of a late-stage study, sending its shares tanking 85 percent. The drug, somavaratan, ...
